Reviewed,
UniProtKB/Swiss-Prot O75365 (TP4A3_HUMAN)
Last modified
June 16, 2009.
Version 65.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein tyrosine phosphatase type IVA 3 EC=3.1.3.48 Alternative name(s): Protein-tyrosine phosphatase 4a3 Protein-tyrosine phosphatase of regenerating liver 3 Short name=PRL-3 Short name=PRL-R | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 173 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis. May be involved in the progression of cardiac hypertrophy by inhibiting intracellular calcium mobilization in response to angiotensin II. Ref.6 Ref.10 |
| Catalytic activity | Protein tyrosine phosphate + H2O = protein tyrosine + phosphate. Ref.12 |
| Enzyme regulation | Inhibited by sodium orthovanadate and peroxovanadium compounds, and by pentamidine. Ref.6 Ref.9 |
| Subunit structure | Interacts with tubulin. Ref.8 |
| Subcellular location | |
| Tissue specificity | Mainly expressed in cardiomyocytes and skeletal muscle; also found in pancreas. Consistently overexpressed in colon cancer metastasis. Ref.6 |
| Post-translational modification | Farnesylated. Farnesylation is required for membrane targeting By similarity. |
| Involvement in disease | Significantly overexpressed in liver metastasis of colorectal cancer. |
| Sequence similarities | Belongs to the protein-tyrosine phosphatase family. Contains 1 tyrosine-protein phosphatase domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Endosome Membrane |
| Coding sequence diversity | Alternative splicing |
| Molecular function | Hydrolase Protein phosphatase |
| PTM | Disulfide bond Lipoprotein Prenylation |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | protein amino acid dephosphorylation Inferred from electronic annotation. Source: InterPro |
| Cellular component | early endosome Inferred from electronic annotation. Source: UniProtKB-SubCell plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | identical protein binding Inferred from physical interaction. Source: IntAct prenylated protein tyrosine phosphatase activityTraceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform 1 (identifier: O75365-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O75365-2) The sequence of this isoform differs from the canonical sequence as follows: 111-135: Missing. | ||||||
| Note: Unstructured and inactive. | ||||||
| Isoform 3 (identifier: O75365-3) Also known as: short; The sequence of this isoform differs from the canonical sequence as follows: 39-124: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 173 | 173 | Protein tyrosine phosphatase type IVA 3 | PRO_0000094788 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Domain | 82 – 148 | 67 | Tyrosine-protein phosphatase | ||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||
| Active site | 72 | 1 | Proton donor Probable | ||||||||||||||||||||||||||||||||
| Active site | 104 | 1 | Phosphocysteine intermediate | ||||||||||||||||||||||||||||||||
| Binding site | 110 | 1 | Substrate | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Lipidation | 170 | 1 | S-farnesyl cysteine By similarity | ||||||||||||||||||||||||||||||||
| Disulfide bond | 49 ↔ 104 | Ref.12 | |||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 39 – 124 | 86 | Missing in isoform 3. | VSP_014406 | |||||||||||||||||||||||||||||||
| Alternative sequence | 111 – 135 | 25 | Missing in isoform 2. | VSP_014407 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 49 | 1 | C → A: No effect on enzymatic activity. Ref.12 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 71 | 1 | D → A: No effect on enzymatic activity. Ref.12 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 72 | 1 | D → A: Abolishes enzymatic activity. Ref.12 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 104 | 1 | C → A or S: 95% loss of enzymatic activity. Ref.6 Ref.10 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 104 | 1 | C → S: Reduces migration-promoting activity. Ref.6 Ref.10 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 111 | 1 | A → S: Enhances catalytic activity. Ref.12 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 140 | 1 | A → R in AAC29314. Ref.1 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 10 – 14 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 17 – 22 | 6 | |||||||||||||||||||||||||||||||||
| Helix | 30 – 40 | 11 | |||||||||||||||||||||||||||||||||
| Beta strand | 45 – 49 | 5 | |||||||||||||||||||||||||||||||||
| Helix | 55 – 61 | 7 | |||||||||||||||||||||||||||||||||
| Beta strand | 65 – 68 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 79 – 94 | 16 | |||||||||||||||||||||||||||||||||
| Beta strand | 99 – 103 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 107 – 110 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 111 – 119 | 9 | |||||||||||||||||||||||||||||||||
| Helix | 120 – 122 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 125 – 135 | 11 | |||||||||||||||||||||||||||||||||
| Helix | 144 – 152 | 9 | |||||||||||||||||||||||||||||||||
| Turn | 156 – 158 | 3 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Zeng Q., Tan Y.H., Hong W. Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Full-length of some muscular transcripts, Telethon (Italy) project B41." Ievolella C., Stanchi F., Pacchioni B., Silvia T., Frigimelica E., Scannapieco P., Corso V., Biasio B., Lanfranchi G. Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Skeletal muscle. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Eye. |
| [5] | "Multiple phosphotyrosine phosphatase mRNAs are expressed in the human lung fibroblast cell line WI-38." Dayton M.A., Knobloch T.J. Recept. Signal Transduct. 7:241-256(1997) [PubMed: 9633825] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 93-148 (ISOFORM 1). Tissue: Lung fibroblast. |
| [6] | "Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling." Matter W.F., Estridge T., Zhang C., Belagaje R., Stancato L., Dixon J., Johnson B., Bloem L., Pickard T., Donaghue M., Acton S., Jeyaseelan R., Kadambi V., Vlahos C.J. Biochem. Biophys. Res. Commun. 283:1061-1068(2001) [PubMed: 11355880] [Abstract] Cited for: TISSUE SPECIFICITY, MUTAGENESIS OF CYS-104, ENZYME REGULATION, FUNCTION. |
| [7] | "A phosphatase associated with metastasis of colorectal cancer." Saha S., Bardelli A., Buckhaults P., Velculescu V.E., Rago C., St Croix B., Romans K.E., Choti M.A., Lengauer C., Kinzler K.W., Vogelstein B. Science 294:1343-1346(2001) [PubMed: 11598267] [Abstract] Cited for: OVEREXPRESSION IN COLON CANCER. |
| [8] | "The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis." Wang J., Kirby C.E., Herbst R. J. Biol. Chem. 277:46659-46668(2002) [PubMed: 12235145] [Abstract] Cited for: INTERACTION WITH TUBULIN. |
| [9] | "Pentamidine is an inhibitor of PRL phosphatases with anticancer activity." Pathak M.K., Dhawan D., Lindner D.J., Borden E.C., Farver C., Yi T. Mol. Cancer Ther. 1:1255-1264(2002) [PubMed: 12516958] [Abstract] Cited for: ENZYME REGULATION. |
| [10] | "PRL-3 and PRL-1 promote cell migration, invasion, and metastasis." Zeng Q., Dong J.-M., Guo K., Li J., Tan H.-X., Koh V., Pallen C.J., Manser E., Hong W. Cancer Res. 63:2716-2722(2003) [PubMed: 12782572] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-104. |
| [11] | "Structure of human PRL-3, the phosphatase associated with cancer metastasis." Kim K.-A., Song J.-S., Jee J., Sheen M.R., Lee C., Lee T.G., Ro S., Cho J.M., Lee W., Yamazaki T., Jeon Y.H., Cheong C. FEBS Lett. 565:181-187(2004) [PubMed: 15135076] [Abstract] Cited for: STRUCTURE BY NMR OF 1-173 (ISOFORM 1). |
| [12] | "Structural insights into molecular function of the metastasis-associated phosphatase PRL-3." Kozlov G., Cheng J., Ziomek E., Banville D., Gehring K., Ekiel I. J. Biol. Chem. 279:11882-11889(2004) [PubMed: 14704153] [Abstract] Cited for: STRUCTURE BY NMR OF 1-169 (ISOFORM 1), DISULFIDE BOND, ENZYME ACTIVITY (ISOFORMS 1 AND 2), MUTAGENESIS OF CYS-49; ASP-71; ASP-72 AND ALA-111. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF041434 mRNA. Translation: AAC29314.1. AJ276554 mRNA. Translation: CAC81757.1. BT007303 mRNA. Translation: AAP35967.1. BC003105 mRNA. Translation: AAH03105.1. U87168 mRNA. Translation: AAB47560.1. | |||||||||||||||||||
| IPI | IPI00026647. IPI00217075. IPI00289328. | ||||||||||||||||||
| RefSeq | NP_009010.2. NP_116000.1. XP_001717100.1. | ||||||||||||||||||
| UniGene | Hs.43666 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| DisProt | DP00254. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | O75365. 111 interactions. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000184489. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 100131062. 11156. | ||||||||||||||||||
| KEGG | hsa:100131062. hsa:11156. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GC08P142501. GC08P142502. | ||||||||||||||||||
| H-InvDB | HIX0019234. | ||||||||||||||||||
| HGNC | HGNC:9636. PTP4A3. | ||||||||||||||||||
| HPA | HPA003281. | ||||||||||||||||||
| MIM | 606449. gene. | ||||||||||||||||||
| PharmGKB | PA33979. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOGENOM | O75365. | ||||||||||||||||||
| HOVERGEN | O75365. | ||||||||||||||||||
| OMA | O75365. KAPLEKD. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| BRENDA | 3.1.3.48. 247. | ||||||||||||||||||
| Pathway_Interaction_DB | prlsignalingeventspathway. Signaling events mediated by PRL. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | O75365. | ||||||||||||||||||
| Bgee | O75365. | ||||||||||||||||||
| CleanEx | HS_PTP4A3. | ||||||||||||||||||
| GermOnline | ENSG00000184489. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000387. Tyr_Pase. IPR016130. Tyr_Pase_AS. IPR000242. Tyr_Pase_rcpt/non-rcpt. [Graphical view] | ||||||||||||||||||
| Pfam | PF00102. Y_phosphatase. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS00383. TYR_PHOSPHATASE_1. False negative. PS50056. TYR_PHOSPHATASE_2. 1 hit. PS50055. TYR_PHOSPHATASE_PTP. False negative. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | TP4A3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O75365 Secondary accession number(s): Q8IVN5, Q99849, Q9BTW5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


